This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Anelva Corporation, Ea Pharma Co., Ltd., Niigata University. Active years: 1998-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kanagawa, JP (1999)
- Kanagawa-perfecture, JP (1999)
- Kawasaki, JP (1998 - 2019)
Company Filing History:


Years Active: 1998-2019
Title: Hiroshi Iwata: Innovator in Pharmaceutical and Display Technologies
Introduction
Hiroshi Iwata is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the fields of pharmaceuticals and display technologies. With a total of 4 patents, Iwata's work reflects his innovative spirit and dedication to advancing technology.
Latest Patents
Iwata's latest patents include a megalin antagonist, which features cilastatin or a pharmaceutically acceptable salt as an active component. This invention aims to suppress renal impairment or inner ear disorders induced via megalin by at least one megalin ligand, selected from a group that includes polymyxins, aminoglycoside antibiotics, glycopeptide antibiotics, and cisplatin. Another significant patent is for a black matrix laminated film and reactive sputtering apparatus. This invention enhances color liquid crystal displays by reducing the reflectance of external light, thereby providing clearer images on the screen.
Career Highlights
Throughout his career, Hiroshi Iwata has worked with reputable companies such as Anelva Corporation and Ea Pharma Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative technologies.
Collaborations
Iwata has collaborated with notable individuals in his field, including Akihiko Saito and Nobumasa Aoki. These partnerships have likely enriched his work and led to further advancements in his inventions.
Conclusion
Hiroshi Iwata's contributions to technology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the fields of pharmaceuticals and display technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile